Sponsor Pipeline

Yanbing Li Clinical Trial Pipeline

Data updated daily from ClinicalTrials.gov — last refresh 2026-08-16
2
Active Trials
0
Recruiting
2
Disease Areas
Active Trials by Phase
Phase 4
1
Not specified
1
Active Trials
NCT IDTitleConditionStatus
Phase 4
NCT07173712 Regimen Transition After Short-Term Intensive Insulin Therapy in Type 2 Diabetes Type 2 Diabetes Not Yet Recruiting
Not specified
NCT07198932 Cofrogliptin and Linagliptin as add-on Therapy to Insulin in Type 2 Diabetes Type 2 Diabetes Not Yet Recruiting
Disease Areas
Type 2 Diabetes (2) Diabetes (2)
Get alerts when Yanbing Li's trials change
Status changes, date slips, and new filings — detected daily, delivered to your inbox.
Start monitoring free